These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 9207802

  • 1. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR, Gregori CA, Breen JL.
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [Abstract] [Full Text] [Related]

  • 2. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT.
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [Abstract] [Full Text] [Related]

  • 3. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA, Barakat RR, Hoskins WJ.
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [Abstract] [Full Text] [Related]

  • 4. Management of patients with positive margins after cervical conization.
    Lapaquette TK, Dinh TV, Hannigan EV, Doherty MG, Yandell RB, Buchanan VS.
    Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
    [Abstract] [Full Text] [Related]

  • 5. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG, Bell DA, Lage JM, Goff BA, Feldman S, Rice LW.
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [Abstract] [Full Text] [Related]

  • 6. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL, Jazaeri AA, Lachance JA, Stoler MH, Irvin WP, Rice LW, Andersen WA, Modesitt SC.
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [Abstract] [Full Text] [Related]

  • 7. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R, Puri I, Bristow RE.
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [Abstract] [Full Text] [Related]

  • 8. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG, Duncan A, Quinn M, Rome R.
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [Abstract] [Full Text] [Related]

  • 9. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
    Im DD, Duska LR, Rosenshein NB.
    Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
    [Abstract] [Full Text] [Related]

  • 10. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
    Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD.
    Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
    [Abstract] [Full Text] [Related]

  • 11. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES, Aoyama C, Baquing MA, Beavis A, Silva E, Holschneider C, Cass I.
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [Abstract] [Full Text] [Related]

  • 12. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH, Schorge JO, Lee KR, Sheets EE.
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [Abstract] [Full Text] [Related]

  • 13. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
    Tay EH, Yew WS, Ho TH.
    Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
    Poynor EA, Marshall D, Sonoda Y, Slomovitz BM, Barakat RR, Soslow RA.
    Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
    [Abstract] [Full Text] [Related]

  • 15. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
    Schorge JO, Lea JS, Ashfaq R.
    J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
    [Abstract] [Full Text] [Related]

  • 16. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP, Day ME, Dietrich CS, Tovar MM, Modesitt SC.
    J Reprod Med; 2011 Oct; 56(9-10):376-80. PubMed ID: 22010519
    [Abstract] [Full Text] [Related]

  • 17. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
    Chang DY, Cheng WF, Torng PL, Chen RJ, Huang SC.
    Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
    [Abstract] [Full Text] [Related]

  • 18. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.
    Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF.
    Obstet Gynecol; 1996 Jul; 88(1):82-6. PubMed ID: 8684768
    [Abstract] [Full Text] [Related]

  • 19. Endometrial and endocervical curettage findings at the time of cervical conization.
    Presley JJ, Hernandez E, Mudafort E, Miyazawa K.
    J Reprod Med; 1987 Feb; 32(2):99-102. PubMed ID: 3560085
    [Abstract] [Full Text] [Related]

  • 20. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC, Retherford B, Voskuil S, Rose GS, Alagoz T.
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.